Search research articles
Contact Us
Filters
Showing results (11-20 of 105) with videos related to
Page
of 11
Sort By:
Cancer Science
|
June 29, 2011
Response of subtype-specific human breast cancer-derived cells to poly(ADP-ribose) polymerase and checkpoint kinase 1 inhibition
Hidetaka Shibata, Satoshi Miuma, Joshua C Saldivar, et al.
Cytogenetic and Genome Research
|
February 16, 2017
Fragile Genes That Are Frequently Altered in Cancer: Players Not Passengers
Jenna R Karras, Morgan S Schrock, Bahadir Batar, et al.
Cellular and Molecular Life Sciences : CMLS
|
October 7, 2014
The FHIT gene product: tumor suppressor and genome "caretaker"
Catherine E Waters, Joshua C Saldivar, Seyed Ali Hosseini, et al.
The Lancet. Oncology
|
December 11, 2002
FHIT: from gene discovery to cancer treatment and prevention
Yuri Pekarsky, Nicola Zanesi, Alexey Palamarchuk, et al.
Advances in Enzyme Regulation
|
November 2, 2010
Hits, Fhits and Nits: beyond enzymatic function
Kay Huebner, Joshua C Saldivar, Jin Sun, et al.
Molecular Cancer
|
December 29, 2017
Impact of FHIT loss on the translation of cancer-associated mRNAs
Daniel L Kiss, William Baez, Kay Huebner, et al.
Journal of Cellular Biochemistry
|
April 9, 2008
Molecular parameters of genome instability: roles of fragile genes at common fragile sites
Flavia Pichiorri, Hideshi Ishii, Hiroshi Okumura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 20, 2007
Wwox and Ap2gamma expression levels predict tamoxifen response
Gulnur Guler, Dimitrios Iliopoulos, Nilufer Guler, et al.
Genes, Chromosomes & Cancer
|
January 21, 2026
Endogenous Processes Underlying Clock-Like Mutational Signatures
Teresa Druck, Rami I Aqeilan, C Marcelo Aldaz, et al.
Oncotarget
|
December 20, 2017
The ubiquitous 'cancer mutational signature' 5 occurs specifically in cancers with deleted <i>FHIT</i> alleles
Stefano Volinia, Teresa Druck, Carolyn A Paisie, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 105) with videos related to
Sort By:
Page
of 11
Cancer Science
|
June 29, 2011
Response of subtype-specific human breast cancer-derived cells to poly(ADP-ribose) polymerase and checkpoint kinase 1 inhibition
Hidetaka Shibata, Satoshi Miuma, Joshua C Saldivar, et al.
Cytogenetic and Genome Research
|
February 16, 2017
Fragile Genes That Are Frequently Altered in Cancer: Players Not Passengers
Jenna R Karras, Morgan S Schrock, Bahadir Batar, et al.
Cellular and Molecular Life Sciences : CMLS
|
October 7, 2014
The FHIT gene product: tumor suppressor and genome "caretaker"
Catherine E Waters, Joshua C Saldivar, Seyed Ali Hosseini, et al.
The Lancet. Oncology
|
December 11, 2002
FHIT: from gene discovery to cancer treatment and prevention
Yuri Pekarsky, Nicola Zanesi, Alexey Palamarchuk, et al.
Advances in Enzyme Regulation
|
November 2, 2010
Hits, Fhits and Nits: beyond enzymatic function
Kay Huebner, Joshua C Saldivar, Jin Sun, et al.
Molecular Cancer
|
December 29, 2017
Impact of FHIT loss on the translation of cancer-associated mRNAs
Daniel L Kiss, William Baez, Kay Huebner, et al.
Journal of Cellular Biochemistry
|
April 9, 2008
Molecular parameters of genome instability: roles of fragile genes at common fragile sites
Flavia Pichiorri, Hideshi Ishii, Hiroshi Okumura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 20, 2007
Wwox and Ap2gamma expression levels predict tamoxifen response
Gulnur Guler, Dimitrios Iliopoulos, Nilufer Guler, et al.
Genes, Chromosomes & Cancer
|
January 21, 2026
Endogenous Processes Underlying Clock-Like Mutational Signatures
Teresa Druck, Rami I Aqeilan, C Marcelo Aldaz, et al.
Oncotarget
|
December 20, 2017
The ubiquitous 'cancer mutational signature' 5 occurs specifically in cancers with deleted <i>FHIT</i> alleles
Stefano Volinia, Teresa Druck, Carolyn A Paisie, et al.
Page
of 11